Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide

Shannon R. McCurdy, Christopher G. Kanakry, Hua Ling Tsai, Yvette L. Kasamon, Margaret M. Showel, Javier Bolaños-Meade, Carol Ann Huff, Ivan Borrello, William H. Matsui, Robert A. Brodsky, Richard F. Ambinder, Maria P. Bettinotti, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide'. Together they form a unique fingerprint.

Medicine & Life Sciences